Related Experiment Video
Updated: Jul 28, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
11-epi-Sinulariolide Acetate-induced Apoptosis in Oral Cancer Cells Is Regulated by FOXO Through Inhibition of
Ting-Shou Chang1,2,3, Jen-Jie Lin4, Kai-Chun Cheng5,6,7
1Department of Otolaryngology-Head and Neck Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, R.O.C.
Background/Aim:
Oral cancer is a general term for carcinomas that occur around the oral tissues, and most are squamous cell carcinoma. Oral cancer is a common disease among Taiwanese males and poses a great threat to national health owing to its high mortality rate. In this study, we used the CAL-27 oral cancer cell lines as in vitro models to investigate the pathways involved in 11-epi-sinulariolide acetate (11-epi-SA)-induced apoptosis.
Materials And Methods:
There have been no previous studies of the anticancer activity of 11-epi-SA isolated from Sinularia flexibilis against oral cancer. We used MTT assay, cell morphologic analysis, DNA fragmentation, TUNEL/DAPI assay, and JC-1 fluorescence staining to analyze the inhibitory effect of 11-epi-SA against the CAL-27 oral cancer cell line and assessed the potential molecular mechanism of apoptosis using western blot.
Results:
Our results showed that 11-epi-SA inhibited CAL-27 cell proliferation, and its effect on cell growth was mediated through an apoptotic pathway mechanism. 11-epi-SA inhibited the PI3K/AKT pathway, allowing downstream FOXO to separate from 14-3-3 and return to the nucleus. We also observed that 11-epi-SA disrupted mitochondrial Bcl family protein homeostasis and activated caspase-3 and caspase-9, which led to apoptosis.
Conclusion:
A low concentration of 11-epi-SA can effectively induce apoptosis in oral cancer cells through the PI3K/AKT/FOXO pathway. 11-epi-SA has great potential as a new drug for the treatment of oral cancer.
Insights
11-epi-sinulariolide acetate (11-epi-SA) induces apoptosis in oral cancer cells by inhibiting the PI3K/AKT/FOXO pathway. This compound shows promise as a novel therapeutic agent for oral cancer treatment.
Area of Science:
- Pharmacology
- Molecular Biology
- Oncology
Background:
- Oral cancer, primarily squamous cell carcinoma, is a significant health concern in Taiwan, particularly among males, due to its high mortality rate.
- 11-epi-sinulariolide acetate (11-epi-SA), a compound isolated from Sinularia flexibilis, has not been previously investigated for its anticancer effects on oral cancer.
Purpose of the Study:
- To investigate the in vitro anticancer activity of 11-epi-SA against the CAL-27 oral cancer cell line.
- To elucidate the molecular mechanisms underlying 11-epi-SA-induced apoptosis in oral cancer cells.
Main Methods:
- MTT assay for cell proliferation inhibition.
- Morphological analysis, DNA fragmentation, TUNEL/DAPI, and JC-1 staining to assess apoptosis.
- Western blot analysis to investigate key apoptotic pathway proteins.
Main Results:
- 11-epi-SA demonstrated significant inhibition of CAL-27 oral cancer cell proliferation.
- The compound induced apoptosis via the PI3K/AKT/FOXO signaling pathway, leading to FOXO nuclear translocation.
- 11-epi-SA disrupted mitochondrial homeostasis and activated caspase-3 and caspase-9, key executioners of apoptosis.
Conclusions:
- 11-epi-SA effectively induces apoptosis in oral cancer cells at low concentrations through the PI3K/AKT/FOXO pathway.
- 11-epi-SA exhibits considerable potential as a novel therapeutic candidate for oral cancer treatment.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The Intrinsic Apoptotic Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Extrinsic Apoptotic Pathway